These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3129194)

  • 1. Transdermal nitroglycerin patches in congestive heart failure: evaluation by continuous hemodynamic monitoring for 72 hours.
    Schneeweiss A; Marmor A
    Cardiologia; 1988 Feb; 33(2):161-4. PubMed ID: 3129194
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nitroglycerin by transdermal route in chronic congestive heart failure].
    Schiavoni G; Mazzari M; Mongiardo R; Frustaci A; Rebuzzi AG; Pennestrì F; Amico C; Bosimini E; Albanese S; Manzoli U
    Cardiologia; 1985 Dec; 30(12):1145-51. PubMed ID: 3939565
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and hemodynamic effects of an isosorbide dinitrate tape on patients with congestive heart failure--comparative study with nitroglycerin ointment].
    Inden M; Itou M; Noda E; Kawahira S; Tanimura H; Takasaki H; Morimoto Y; Nakano T; Takezawa H
    Kokyu To Junkan; 1983 Nov; 31(11):1245-50. PubMed ID: 6427869
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemodynamic effect of unloading therapy in acute myocardial infarction with congestive heart failure].
    Kobayashi A; Hiramatsu S; Katoh Y; Muramatsu J; Kikawada R
    Kokyu To Junkan; 1987 Oct; 35(10):1071-7. PubMed ID: 3122295
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure.
    Armstrong PW
    J Am Coll Cardiol; 1987 Feb; 9(2):420-5. PubMed ID: 3100600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic range of transdermal nitro-patches].
    Lazebnik LB
    Klin Med (Mosk); 1995; 73(5):47-50. PubMed ID: 8815277
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical usefulness of a transdermal nitroglycerin patch as a sustained vasodilator for patients with heart failure].
    Hirosawa K; Sekiguchi M; Hiroe M; Honda T; Matsumoto N; Yasuda H; Kanazawa T; Miura M; Hayakawa H; Takano T
    Kokyu To Junkan; 1987 Mar; 35(3):305-15. PubMed ID: 3108982
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of transdermal nitroglycerin in children with congestive heart failure: a Doppler echocardiographic study.
    Vaksmann G; Pariente-Khayat A; Godart F; Francart C; Rey E; D'Athis P; Pons G; Rey C
    Pediatr Cardiol; 2001; 22(1):11-3. PubMed ID: 11123120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure.
    Sharpe N; Coxon R; Webster M; Luke R
    Am J Cardiol; 1987 Apr; 59(8):895-9. PubMed ID: 3103412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic effect of nitroglycerin gel in cardiac insufficiency secondary to acute myocardial infarction].
    Coma Canella I; López-Sendón J
    Rev Esp Cardiol; 1983; 36(1):43-8. PubMed ID: 6410465
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
    Parker JD; Parker AB; Farrell B; Parker JO
    J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamic effects of nitroglycerin in oral form (Nitrilex Spray)].
    Stejfa M; Vítovec J; Roubalík P; Blaha M
    Vnitr Lek; 1988 Mar; 34(3):237-44. PubMed ID: 3130719
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic-hemodynamic studies of nitroglycerin in congestive cardiac failure.
    Armstrong PW; Armstrong JA; Marks GS
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2429-32. PubMed ID: 6775294
    [No Abstract]   [Full Text] [Related]  

  • 14. Sustained beneficial hemodynamic effects of low transdermal nitroglycerin doses compared with placebo in patients with congestive heart failure.
    Bolognese L; Sarasso G; Rognoni G; Makmur J; Fornaro G; Perucca A; Rossi P
    Clin Cardiol; 1988 Feb; 11(2):79-85. PubMed ID: 3126012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure.
    Roth A; Kulick D; Freidenberger L; Hong R; Rahimtoola SH; Elkayam U
    J Am Coll Cardiol; 1987 Apr; 9(4):858-64. PubMed ID: 3104435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A trial of the use of the transdermal preparation Deponit for treating stenocardia].
    Alliluev IG; Pecherskaia MB; Poltavskaia MG; Syrkin AL
    Ter Arkh; 1996; 68(6):55-8. PubMed ID: 8771688
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure.
    Jordan RA; Seth L; Casebolt P; Hayes MJ; Wilen MM; Franciosa J
    Ann Intern Med; 1986 Mar; 104(3):295-8. PubMed ID: 3080935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transdermal therapeutic system-nitroglycerin in patients with heart failure. Influence on hemodynamic changes.
    Ino-Oka E; Takishima T; Onodera K; Kato M; Hayashi M; Yasui S
    Jpn J Med; 1989; 28(6):697-708. PubMed ID: 2517442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravenous molsidomine administration in heart failure. Part II: Comparison with nitroglycerin and effectiveness in nitrate tolerance].
    Störk T; Möckel M; Danne O; Müller R; Eichstädt H; Hochrein H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():50-3. PubMed ID: 7968904
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intravenous nitroglycerin infusion in patients with acute heart failure].
    Svensson G; Strandberg LE; Erhardt L
    Lakartidningen; 1986 Apr; 83(14):1282-4. PubMed ID: 3084893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.